Starling Oncology, Inc. Increase (Decrease) in Other Operating Assets
Starling Oncology, Inc. (STLN) reported Increase (Decrease) in Other Operating Assets of $198.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2022-03-11
- Starling Oncology, Inc. increase (decrease) in other operating assets for fiscal 2021 was $198.00K, a 692.00% increase from fiscal 2020.
- Starling Oncology, Inc. increase (decrease) in other operating assets for fiscal 2020 was $25.00K.
| Period end | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|
| 2021-12-31 | $198.00K 10-K · filed 2022-03-11 |
| 2020-12-31 | $25.00K 10-K · filed 2022-03-11 |